Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 4,107 | 3,743 | 3,723 | 2,966 | 4,910 |
| Cost of Goods | 2,505 | 2,122 | 2,000 | 1,683 | 2,674 |
| Gross Profit | 1,602 | 1,621 | 1,723 | 1,283 | 2,236 |
| Operating Expenses | 2,482 | 2,378 | 1,974 | 2,657 | 2,714 |
| Operating Income | -375 | -634 | -252 | -691 | 197 |
| Other Income | -67 | 828 | -71 | -75 | -334 |
| Pre-tax Income | -441 | 193 | -323 | -766 | -137 |
| Income Tax | 0 | 5 | 0 | N/A | -15 |
| Net Income Continuous | -441 | 189 | -323 | -766 | -122 |
| Net Income | $-441 | $189 | $-323 | $-766 | $-122 |
| EPS Basic Total Ops | -0.06 | 0.03 | -0.04 | -0.11 | -0.02 |
| EPS Basic Continuous Ops | -0.06 | 0.03 | -0.04 | -0.11 | -0.02 |
| EPS Diluted Total Ops | -0.06 | 0.03 | -0.04 | -0.11 | -0.02 |
| EPS Diluted Continuous Ops | -0.06 | 0.03 | -0.04 | -0.11 | -0.02 |
| EBITDA(a) | $247 | $-19 | $351 | $-117 | $855 |